| [1] |
Santiwarangkool, S.; Akita, H.; Khalil, I.A.; Abd Elwakil, M.M.; Sato, Y.; Kusumoto, K.; Harashima, H. A study of the endocytosis mechanism and transendothelial activity of lung-targeted GALA-modified liposomes.J. Control. Release. 2019, 307, 55–63.
|
| [2] |
Saigal, A.; Ng, W.K.; Tan, R.B.H.; Chan, S.Y. Development of controlled release inhalable polymeric microspheres for treatment of pulmonary hypertension. Int. J. Pharm. 2013, 450, 114–122.
|
| [3] |
Feng, T.S.; Tian, H.Y.; Xu, C.N.; Lin, L.; Xie, Z.G.; Lam, M.H.W.; Liang, H.J.; Chen, X.S. Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment. Eur. J. Pharm. Biopharm. 2014, 88, 1086–1093.
|
| [4] |
Grenha, A.; Remuñán-López, C.; Carvalho, E.L.S.; Seijo, B. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins. Eur. J. Pharm. Biopharm. 2008, 69, 83–93.
|
| [5] |
Yang, T.T.; Wen, B.F.; Liu, K.; Qin, M.; Gao, Y.Y.; Ding, D.J.; Li, W.T.; Zhang, Y.X.; Zhang, W.F. Cyclosporine A/porous quaternized chitosan microspheres as a novel pulmonary drug delivery system. Artif. Cells Nanomed. Biotechnol. 2018, 46, 552–564.
|
| [6] |
Hirota, K.; Hasegawa, T.; Nakajima, T.; Inagawa, H.; Kohchi, C.; Soma, G.I.; Makino, K.; Terada, H. Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis. J. Control. Release. 2010, 142, 339–346.
|
| [7] |
Manconi, M.; Manca, M.L.; Valenti, D.; Escribano, E.; Hillaireau, H.; Fadda, A.M.; Fattal, E. Chitosan and hyaluronan coated liposomes for pulmonary administration of curcumin. Int. J. Pharm. 2017, 525, 203–210.
|
| [8] |
Gidwani, B.; Vyas, A. A comprehensive review on cyclodextrin-based carriers for delivery of chemotherapeutic cytotoxic anticancer drugs. Biomed. Res. Int. 2015, 2015, 198268.
|
| [9] |
Gaspar, M.C.; Sousa, J.J.S.; Pais, A.A.C.C.; Cardoso, O.; Murtinho, D.; Serra, M.E.S.; Tewes, F.; Olivier, J.C. Optimization of levofloxacin-loaded crosslinked chitosan microspheres for inhaled aerosol therapy. Eur. J. Pharm. Biopharm. 2015, 96, 65–75.
|
| [10] |
Park, J.H.; Jin, H.E.; Kim, D.D.; Chung, S.J.; Shim, W.S.; Shim, C.K. Chitosan microspheres as an alveolar macrophage delivery system of ofloxacin via pulmonary inhalation. Int. J. Pharm. 2013, 441, 562–569.
|
| [11] |
Saraogi, G.K.; Gupta, P.; Gupta, U.D.; Jain, N.K.; Agrawal, G.P. Gelatin nanocarriers as potential vectors for effective management of tuberculosis. Int. J. Pharm. 2010, 385, 143–149.
|
| [12] |
Yamada, K.; Kamada, N.; Odomi, M.; Okada, N.; Nabe, T.; Fujita, T.; Kohno, S.; Yamamoto, A. Carrageenans can regulate the pulmonary absorption of antiasthmatic drugs and their retention in the rat lung tissues without any membrane damage. Int. J. Pharm. 2005, 293, 63–72.
|
| [13] |
Athamneh, T.; Amin, A.; Benke, E.; Ambrus, R.; Leopold, C.S.; Gurikov, P.; Smirnova, I. Alginate and hybrid alginate-hyaluronic acid aerogel microspheres as potential carrier for pulmonary drug delivery. J. Supercrit. Fluids. 2019, 150, 49–55.
|
| [14] |
Diab, R.; Brillault, J.; Bardy, A.; Gontijo, A.V.L.; Olivier, J.C. Formulation and in vitro characterization of inhalable polyvinyl alcohol-free rifampicin-loaded PLGA microspheres prepared with sucrose palmitate as stabilizer: Efficiency for ex vivo alveolar macrophage targeting. Int. J. Pharm. 2012, 436, 833–839.
|
| [15] |
Doan, T.V.P.; Couet, W.; Olivier, J.C. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery. Int. J. Pharm. 2011, 414, 112–117.
|
| [16] |
Ohashi, K.; Kabasawa, T.; Ozeki, T.; Okada, H. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis. J. Control. Release. 2009, 135, 19–24.
|
| [17] |
Rawat, A.; Majumder, Q.H.; Ahsan, F. Inhalable large porous microspheres of low molecular weight heparin: In vitro and in vivo evaluation. J. Control. Release. 2008, 128, 224–232.
|
| [18] |
Silva, D.M.; Paleco, R.; Traini, D.; Sencadas, V. Development of ciprofloxacin-loaded poly(vinyl alcohol) dry powder formulations for lung delivery. Int. J. Pharm. 2018, 547, 114–121.
|
| [19] |
Gaspar, M.C.; Pais, A.A.C.C.; Sousa, J.J.S.; Brillaut, J.; Olivier, J.C. Development of levofloxacin-loaded PLGA microspheres of suitable properties for sustained pulmonary release. Int. J. Pharm. 2019, 556, 117–124.
|
| [20] |
Kapoor, D.N.; Bhatia, A.; Kaur, R.; Sharma, R.; Kaur, G.; Dhawan, S. PLGA: a unique polymer for drug delivery. Ther. Deliv. 2015, 6, 41–58.
|
| [21] |
Huang, H.; Wang, Y.X.; Jiang, C.G.; Lang, L.W.; Wang, H.Y.; Chen, Y.; Zhao, Y.; Xu, Z.J. Intrapulmonary concentration of levofloxacin in patients with idiopathic pulmonary fibrosis. Pulm. Pharmacol. Ther. 2014, 28, 49–52.
|
| [22] |
Govender, T.; Stolnik, S.; Garnett, M.C.; Illum, L.; Davis, S.S. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J. Control. Release. 1999, 57, 171–185.
|
| [23] |
Disratthakit, A.; Doi, N.; Takenaga, M.; Ohta, Y. Anti-tuberculosis activity and drug interaction with nevirapine of inhalable lipid microspheres containing rifampicin in murine model. J. Microencapsul. 2010, 27, 365–371.
|
| [24] |
Mura, S.; Hillaireau, H.; Nicolas, J.; Kerdine-Römer, S.; Le Droumaguet, B.; Deloménie, C.; Nicolas, V.; Pallardy, M.; Tsapis, N.; Fattal, E. Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells. Biomacromolecules. 2011, 12, 4136–4143.
|
| [25] |
Bianco, I.D.; Balsinde, J.; Beltramo, D.M.; Castagna, L.F.; Landa, C.A.; Dennis, E.A. Chitosan-induced phospholipase A2 activation and arachidonic acid mobilization in P388D1 macrophages. FEBS Lett. 2000, 466, 292–294.
|
| [26] |
Ventura, C.A.; Tommasini, S.; Crupi, E.; Giannone, I.; Cardile, V.; Musumeci, T.; Puglisi, G. Chitosan microspheres for intrapulmonary administration of moxifloxacin: Interaction with biomembrane models and in vitro permeation studies. Eur. J. Pharm. Biopharm. 2008, 68, 235–244.
|
| [27] |
Giovagnoli, S.; Blasi, P.; Schoubben, A.; Rossi, C.; Ricci, M. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery. Int. J. Pharm. 2007, 333, 103–111.
|
| [28] |
Sakagami, M.; Kinoshita, W.; Sakon, K.; Sato, J.I.; Makino, Y. Mucoadhesive beclomethasone microspheres for powder inhalation: their pharmacokinetics and pharmacodynamics evaluation. J. Control. Release. 2002, 80, 207–218.
|
| [29] |
Rodrigues, S.; Cordeiro, C.; Seijo, B.; Remuñán-López, C.; Grenha, A. Hybrid nanosystems based on natural polymers as protein carriers for respiratory delivery: Stability and toxicological evaluation. Carbohydr. Polym. 2015, 123, 369–380.
|
| [30] |
Varshosaz, J.; Taymouri, S.; Hamishehkar, H. Fabrication of polymeric nanoparticles of poly(ethylene-co-vinyl acetate) coated with chitosan for pulmonary delivery of carvedilol. J. Appl. Polym. Sci. 2014, 131, 39694.
|
| [31] |
Du, P.; Du, J.; Smyth, H.D.C. Evaluation of granulated lactose as a carrier for dry powder inhaler formulations 2: effect of drugs and drug loading. J. Pharm. Sci. 2017, 106, 366–376.
|
| [32] |
Feng, R.H.; Zhang, Z.Y.; Li, Z.W.; Huang, G.H. Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery. Drug Deliv. 2014, 21, 185–192.
|
| [33] |
Wanakule, P.; Liu, G.W.; Fleury, A.T.; Roy, K. Nano-inside-micro: Disease-responsive microgels with encapsulated nanoparticles for intracellular drug delivery to the deep lung. J. Control. Release. 2012, 162, 429–437.
|
| [34] |
Kolesnyk, I.; National University of Kiev Mohyla Academy Skovoroda str Kiev Ukraine, Konovalova, V.; Burban, A.; National University of Kiev Mohyla Academy Skovoroda str Kiev Ukraine, National University of Kiev Mohyla Academy Skovoroda str Kiev Ukraine. Alginate/κ-carrageenan microspheres and their application for protein drugs controlled release. Chem. Chem. Technol. 2015, 9, 485–492.
|
| [35] |
Hwang, S.M.; Kim, D.D.; Chung, S.J.; Shim, C.K. Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis. J. Control. Release. 2008, 129, 100–106.
|
| [36] |
Sah, E.; Sah, H. Recent trends in preparation of poly(lactide-co-glycolide) nanoparticles by mixing polymeric organic solution with antisolvent. J. Nanomater. 2015, 2015, 1–22.
|
| [37] |
Luinstra, M.; Grasmeijer, F.; Hagedoorn, P.; Moes, J.R.; Frijlink, H.W.; de Boer, A.H. A levodopa dry powder inhaler for the treatment of Parkinson's disease patients in off periods. Eur. J. Pharm. Biopharm. 2015, 97, 22–29.
|
| [38] |
Lakio, S.; Morton, D.A.V.; Ralph, A.P.; Lambert, P. Optimizing aerosolization of a high-dose L-arginine powder for pulmonary delivery. Asian J. Pharm. Sci. 2015, 10, 528–540.
|
), Esti Hendradi1, Herlina Eka Pratama1, Mahardian Rahmadi2
>
>7-545/img_1.jpg)
7-545/img_3.jpg)